A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 38, Issue 7, 2011, Pages 1123-1126

  Koyama, Hiroshi ^a   Iesato, Asumi ^a   Fukushima, Yuko ^a   Okada, Toshihiro ^a   Watanabe, Takayuki ^a   Harada, Michihiko ^a   Ito, Tokiko ^a   Maeno, Kazuma ^a   Mochizuki, Yasuhiro ^a   Ito, Kenichi ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aromatase inhibitor; Breast cancer; High dose toremifene treatment

Indexed keywords

TOREMIFENE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; TREATMENT RESPONSE;

EID: 80052759076     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hortobagyi GN: Treatment of breast cancer. N Engl J Med 339: 974-984, 1998.
2. Pyrhonen S, Ellmen J, Vuorinen J, et al: Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal woman with breast cancer. Breast Cancer Res Treat 56: 133-143, 1999. (Pubitemid 29494831)
3. Harvey H, Kimura M and Hajba A: Toremifene: an evaluation of its safety profile. Breast 15: 142-157, 2006. (Pubitemid 44268919)
4. Yamamoto Y, Masuda N, Ohtake T, et al: Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor. Breast Cancer Aug 15, 2009 [Epub ahead of print]
5. Harold AH: Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma. Cancer 80: 1646-1651, 1997.
6. J Jpn Soc Cancer Ther 28(5): 826-834, 1993.